TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Novartis: Powering into the Multiple Sclerosis Market Richard Sater submits:Most pharmaceutical companies fuel their growth by creating more product lines within their core strengths. Entering highly contested therapeutic areas is a risky endeavor, but one a large pharmaceutical company is capable of funding. Novartis (NVS) currently has only a moderate presence in Neurology, with modestly successful products including Exelon for Alzheimer’s and Stalevo for Parkinson’s. Novartis is employing several strategies to enter the field of Multiple Sclerosis therapeutics. Strategies employed include in-house development, early to mid-stage partnering and development of bio-generics. Further details of current studies and future potential of these agents and others are further explored in reports available through neuropipeline.com.Complete Story » seekingalpha.com |
Health Care Divides German Coalition German Chancellor Merkel's incoming government is already at odds over how to deal with the health-care system, whose funding is coming under increasing strain. online.barrons.com |
Adolor Corp. Q3 2009 Earnings Conference Call Adolor Corp. (ADLR)Q3 2009 Earnings CallOctober 29, 2009 08:45 a.m. ET Complete Story » seekingalpha.com |
Pelosi Open to Medicare Deal Pelosi expressed support for a Senate Democratic plan to expand Medicare, raising the prospect of a bicameral agreement on a health bill. online.wsj.com |
Restaurants Begin to Count Calories Restaurants like Applebee's and Starbucks tweak their menus to include healthier food items as health-care debate gathers steam. online.wsj.com |